Rigel Pharmaceuticals (RIGL) Research & Development (2016 - 2025)
Historic Research & Development for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Q3 2025 value amounting to $7.4 million.
- Rigel Pharmaceuticals' Research & Development rose 1894.21% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 million, marking a year-over-year increase of 3490.97%. This contributed to the annual value of $23.4 million for FY2024, which is 465.7% down from last year.
- Per Rigel Pharmaceuticals' latest filing, its Research & Development stood at $7.4 million for Q3 2025, which was up 1894.21% from $6.8 million recorded in Q2 2025.
- In the past 5 years, Rigel Pharmaceuticals' Research & Development registered a high of $18.3 million during Q3 2021, and its lowest value of $3.2 million during Q4 2023.
- In the last 5 years, Rigel Pharmaceuticals' Research & Development had a median value of $8.4 million in 2025 and averaged $10.3 million.
- Per our database at Business Quant, Rigel Pharmaceuticals' Research & Development plummeted by 7926.46% in 2023 and then soared by 7677.34% in 2024.
- Over the past 5 years, Rigel Pharmaceuticals' Research & Development (Quarter) stood at $13.3 million in 2021, then increased by 15.49% to $15.4 million in 2022, then crashed by 79.26% to $3.2 million in 2023, then surged by 76.77% to $5.6 million in 2024, then skyrocketed by 30.56% to $7.4 million in 2025.
- Its Research & Development was $7.4 million in Q3 2025, compared to $6.8 million in Q2 2025 and $8.4 million in Q1 2025.